HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gustavo E Velásquez Selected Research

Gustavo E Velásquez Research Topics

Disease

8Tuberculosis (Tuberculoses)
04/2024 - 07/2014
3Pulmonary Tuberculosis
04/2024 - 01/2018
3COVID-19
02/2023 - 01/2022
3Infections
10/2020 - 01/2016
3Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
03/2017 - 07/2014
1Exanthema (Rash)
04/2024
1Vomiting
04/2024
1Nausea
10/2020
1Bacterial Pneumonia
10/2020
1Mycoses (Diseases, Fungus)
01/2018
1Rheumatoid Arthritis
01/2018
1Histoplasmosis
01/2018
1Ebola Hemorrhagic Fever
01/2016

Drug/Important Bio-Agent (IBA)

4Rifampin (Rifampicin)FDA LinkGeneric
03/2024 - 07/2014
3PyrazinamideFDA LinkGeneric
04/2024 - 11/2016
3Isoniazid (Ftivazide)FDA LinkGeneric
04/2024 - 07/2014
1Transaminases (Aminotransferases)IBA
04/2024
1Moxifloxacin (Avelox)FDA Link
04/2024
1rifapentine (Priftin)FDA Link
04/2024
1Immunoglobulin G (IgG)IBA
02/2023
1Immunoglobulin M (IgM)IBA
02/2023
1RifamycinsIBA
01/2023
1pretomanidIBA
01/2023
1COVID-19 VaccinesIBA
09/2022
1AntigensIBA
01/2022
1omadacyclineIBA
10/2020
1Drug CombinationsIBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1Abatacept (Orencia)FDA Link
01/2018
1VaccinesIBA
01/2016
1FluoroquinolonesIBA
07/2014

Therapy/Procedure

4Therapeutics
10/2020 - 07/2014